Section Arrow
RNAC.NASDAQ
- Cartesian Therapeutics
Quotes are at least 15-min delayed:2025/06/10 23:45 EDT
Last
 10.77
-0.08 (-0.74%)
Day High 
11.31 
Prev. Close
10.85 
1-M High
11.48 
Volume 
50.57K 
Bid
8
Ask
15.5
Day Low
10.5133 
Open
10.9 
1-M Low
8.46 
Market Cap 
281.60M 
Currency USD 
P/E 1.99 
%Yield -- 
10-SMA 9.81 
20-SMA 9.88 
50-SMA 10.86 
52-W High 29.65 
52-W Low 8.46 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
5.33/-3.71
Enterprise Value
292.74M
Balance Sheet
Book Value Per Share
-0.84
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
26.00M
Operating Revenue Per Share
0.32
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CARMCarisma Therapeutics1.11+0.8832+389.42%-- 
KLTOKlotho Neurosciences Inc2.01+0.19+10.44%-- 
WINTWindtree Therapeutics Inc.0.7999+0.2428+43.58%0.84PE
EVGNEvogene Ltd.2.26+1.13+100.00%0.3PE
TNFATNF Pharmaceuticals Inc.0.1761+0.0071+4.20%-- 
Quotes are at least 15-min delayed:2025/06/10 23:45 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The companyleverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.